DCVax-L Vaccination in Patients with Glioblastoma: Real Promise or Negative Trial? The Debate Is Open

SIMPLE SUMMARY: Glioblastoma is the most common of primary brain tumors, accounting for approximately 50% of intracranial malignancies. It is an aggressive neoplasm with a poor prognosis. To date, the standard of care is a treatment involving maximal surgery, radiotherapy concurrent with and followe...

Descripción completa

Detalles Bibliográficos
Autores principales: Gatto, Lidia, Di Nunno, Vincenzo, Tosoni, Alicia, Bartolini, Stefania, Ranieri, Lucia, Franceschi, Enrico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296384/
https://www.ncbi.nlm.nih.gov/pubmed/37370860
http://dx.doi.org/10.3390/cancers15123251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296384/
https://www.ncbi.nlm.nih.gov/pubmed/37370860
http://dx.doi.org/10.3390/cancers15123251

Ejemplares similares